RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: Some of the more classical chemists still do not get the difference between the generative approach and the older metho…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: Next-gen AI "imagined" the molecules with the desired drug-like properties in 46 days. Validated in human cells and PK…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: Some of the more classical chemists still do not get the difference between the generative approach and the older metho…
Some of the more classical chemists still do not get the difference between the generative approach and the older methods and criticize the molecules. It is not about the molecules but rather how they are designed. One day GANs will be everywhere. https:
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @davidasinclair: Have to agree with Eric. Alex and the team at @InSilicoMeds are doing incredible stuff 👏 @biogerontology #AI https://t…
Have to agree with Eric. Alex and the team at @InSilicoMeds are doing incredible stuff 👏 @biogerontology #AI
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
Disrupting Medicine: AI can now quickly 'visualize' which specific set of molecules containing the desired drug properties targeted at certain disease ⚕ 📰 More info: https://t.co/b6rIFuvi8I 💡 Research paper: https://t.co/grtHLvUDN2 #biotech 🏷 #AI 🏷 #Dru
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: Next-gen AI "imagined" the molecules with the desired drug-like properties in 46 days. Validated in human cells and PK…
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
This is really cool cc: @DNA140 @monocle_ml
RT @NvidiaAI: Congrats to #startup @inSilicoMeds for their work in #drugdiscovery, which demonstrates “the power of #AI, using a GAN approa…
RT @biogerontology: Next-gen AI "imagined" the molecules with the desired drug-like properties in 46 days. Validated in human cells and PK…
RT @BioPharmaJosh: Insilico Medicine will present at 6th @BioCentury BayHelix China Healthcare Summit in November in Shanghai. Arrive early…
Insilico Medicine will present at 6th @BioCentury BayHelix China Healthcare Summit in November in Shanghai. Arrive early. It will be a packed house. https://t.co/vTjdrAwF2Z
@jarokrolewski We will do it with AI ;) https://t.co/V0DbGUit3Z
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Next-gen AI "imagined" the molecules with the desired drug-like properties in 46 days. Validated in human cells and PK confirmed in mice. The study was published in @NatureBiotech. @InSilicoMeds @A_Aspuru_Guzik @VectorInst @UofT @WuXi_AppTec https://t.co/
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
إن ممتاز في أحد شوارع في وزارة التربية الوطنية والتكوين في
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/7kZyxmjnBZ #DeepLearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Researchers from @InSilicoMeds published a paper in @NatureBiotech about using #AI to significantly decrease the amount of time it takes to create molecules useful for drug discovery: https://t.co/zHos0dmaQt https://t.co/XrWi0QKRLu
RT @Datascience__: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/2zy78jKfeB #DeepLearning
RT @bharatinturi: "AI system can create novel drug candidates in just 46 days, study finds" @YahooNews , #insilico #insilicomedicine #ai #D…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EIzumchenko: Alex Zhavoronkov, the author of this landmark paper and a frequent collaborator is presenting at our department @UChicagoM…
RT @biogerontology: I will be presenting this paper at the @ACCP1_org in Chicago today. We can disrupt #ClinicalPharmacology if we find a w…
The breakthrough AI work on Drug Discovery #insilico #insilicomedicine #ai #DDR1, #Nature #insilicomeds, published in #NatureBiotech, #InsilicoAI @biogerontology https://t.co/BJXZmCDqcy
@elonmusk Check out our new paper. No danger in AI. Only hope. https://t.co/yINot3PBqH
RT @nn_medicine: Глубокое обучение с успехом используется в дизайне малых молекул de novo #DeepLearning модель GENTRL позволила обнаружить…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EIzumchenko: Alex Zhavoronkov, the author of this landmark paper and a frequent collaborator is presenting at our department @UChicagoM…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @Datascience__: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/2zy78jKfeB #DeepLearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Deep learning scientists used their advanced AI system to come up with potent drug element in just a few days instead of years of traditional drug research and development ⚛️ #biotech 🏷 #Healthinnovations 📰 Details: https://t.co/rjfVs9SB8n 💡 Science: ht
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/2zy78jKfeB #DeepLearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @IraneusOgu: So a new day has come for pharma and healthcare as we know it. With AI @biogerontology and @InSilicoMeds are doing for phar…
RT @drsxr: This seems really interesting - Hybrid GAN and RL method for drug (small-molecule) design. HT to @Gopal_Karemore at Novo Nordis…